Skip to main content

Clinical Trials

  • Jonathan P. Wanderer

    Jonathan P. Wanderer

    Dr. Jon Wanderer is a nationally recognized leader in clinical informatics and perioperative care innovation. As Associate Chief Medical Information Officer at Vanderbilt University Medical Center, he designs and implements digital solutions that enhance surgical workflows, streamline inpatient…

    Read More

  • George T. Nicholson

    George T. Nicholson

    Dr. George Nicholson is a pediatric interventional cardiologist and co-founder of Influent Medical, a startup developing minimally invasive devices for infants with congenital heart disease. His work focuses on improving early outcomes for newborns with hypoplastic left heart syndrome through…

    Read More

  • Vanderbilt-Discovered Compound Advances to Phase 1 Clinical Trial as a Promising New Treatment for Schizophrenia

    Neumora Therapeutics, Inc. has announced the launch of a Phase 1 clinical study evaluating NMRA-861 in healthy adult participants and adults with stable schizophrenia.

    Read More

  • Adam D. Yock

    Adam D. Yock

    Dr. Adam Yock is a medical physicist and technology leader advancing precision cancer treatment through smarter, more adaptable radiation therapy. As Director of Technology and Innovation in Vanderbilt’s Department of Radiation Oncology, he oversees the clinical integration of advanced…

    Read More

  • Lauren Williamson

    Lauren Williamson

    Dr. Lauren Williamson is a translational immunologist developing next-generation antibody therapeutics for infectious diseases, cancer, and autoimmunity. At Vanderbilt, she leads efforts in antibody discovery and engineering, with a focus on monoclonal and bispecific formats, expression…

    Read More